Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Parkinson’s disease: Desulfovibrio bacteria have been found guilty
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Parkinson’s disease: Desulfovibrio bacteria have been found guilty
Gastroenterology

Parkinson’s disease: Desulfovibrio bacteria have been found guilty

Parkinson's disease
Gastroenterology Neurology

So suspect scientists. Desulfovibrio bacteria in the gut have recently been accused of inducing aggregates in the digestive system which then spread to the brain via the vagal nerve.

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 13 September 2023
Updated 04 September 2024

In Parkinson’s disease, alpha-synuclein (alpha-syn) proteins are found to accumulate, in the form of Lewy bodies, in the brain, as well as in numerous other tissues and organs, including the spinal cord, autonomic nerves, myocardial tissue, and the human digestive tract. Some scientists suspect Desulfovibrio bacteria to be involved in the formation of these gut aggregates, which spread in a (sidenote: Prion Prions are infectious agents composed of proteins and are associated with specific types of neurodegenerative diseases. For example, bovine spongiform encephalopathy (BSE or “mad cow disease”) is a prion disease that affects cattle and whose human variant is Creutzfeldt-Jakob disease (CJD).

Source: https://www.who.int/fr/news-room/fact-sheets/detail/food-safety
)
-like manner to the brain via the vagal nerve. Desulfovibrio appears with greater frequency and abundance in Parkinson’s patients, particularly in severe forms of the disease. Are these bacteria, which are known to produce hydrogen sulfide (H2S), really capable of this? A Finnish study on animals attempted to find out, using a C. elegans nematode model expressing human alpha-syn.

10 patients, 10 spouses and nematodes

Three strains of Desulfovibrio (D. desulfuricans, D. fairfieldensis and D. piger) were isolated from the fecal samples of 10 Parkinson’s patients and their 10 healthy spouses at a clinic in Finland. These bacteria were then used to feed the nematodes. In parallel, other worms were fed Escherichia coli MC4100 that produces curli, an amyloid fiber that facilitates alpha-syn aggregation (positive control). A final group of worms were fed a diet containing E. coli LSR11, which is incapable of producing curli (negative control).

8.5 million Global estimates in 2019 showed over 8.5 million individuals with Parkinson disease.

2x The prevalence of Parkinson disease has doubled in the past 25 years.

329 000 Parkinson disease caused 329 000 deaths, an increase of over 100% since 2000. Men are more affected than women.

(sidenote: https://www.who.int/news-room/fact-sheets/detail/parkinson-disease )

An effect on brain aggregates

By studying head sections of the worms, it was found that all three strains of Desulfovibrio induced aggregates in the worms’ heads. Those taken from the stools of Parkinson’s patients seemed “more effective” than those taken from the healthy spouses: the worms displayed aggregates that were greater in number and size. Furthermore, worms fed with D. desulfuricans and, to a lesser extent, with D. fairfieldensis harbored significantly larger alpha-syn aggregates than worms fed with D. piger. 

An effect on mortality

In terms of survival, after four days, mortality was higher in the group of worms fed with Desulfovibrio from Parkinson’s patients. This increased mortality may be explained by the apparently greater virulence of the bacteria they received, making the bacteria more toxic and inducing more aggregates, at a level that became lethal. The authors believe that the greater virulence of the strains from Parkinson’s patients may relate to the greater or lesser capacity of Desulfovibrio to produce H2S. Indeed, hydrogen sulfide may be involved in alpha-syn aggregation, facilitating the release of cytochrome c from mitochondria.

While this study demonstrates that Desulfovibrio bacteria can increase the number and size of alpha-syn aggregates, many questions remain unanswered, including whether the mechanisms involved include H2S production. Is the presence of these bacteria in stool enough to identify those suffering from the disease? Above all, could eradicating or limiting these pathogenic bacteria help prevent Parkinson’s disease?

Sources

Huynh VA, Takala TM, Murros KE et al. Desulfovibrio bacteria enhance alpha-synuclein aggregation in a Caenorhabditis elegans model of Parkinson's disease. Front Cell Infect Microbiol. 2023 May 1;13:1181315.

Tags
Gut-brain axis Mental health Parkinson’s disease Microbiome Flora

    See also

    Parkinson : le microbiote intestinal, chef d’orchestre des mécanismes pathogéniques ? Does the gut microbiota orchestrate pathogenic mechanisms in Parkinson’s disease?
    Article PRO Reponse maladie parkinson Interference of the gut microbiota with the treatment of parkinson’s disease
    Created 13 September 2023
    Updated 04 September 2024

    About this article

    To know more about this topic.

    Main topic

    Parkinson's disease

    Medical practice

    Gastroenterology Neurology

    Content type

    News
    Gastroenterology

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial...

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irrita...

    Find out more

    Probiotics: what exactly are we talking about?

    From the Latin pro and Greek bios meaning “for life”, the term “probiotic” was suggested over 60 year...

    Find out more

    How do you choose a probiotic for your patient?

    Faced with a plethora of products on the market, it's not always easy for health professionals to sug...

    Find out more

    The Janus face of Antibiotics: Life Savers and Microbiota Disruptors

    A page turns: with the advent of antibiotics in the...

    Find out more

    Fecal transplantation - ready for prime time?

    Congress review By Pr. Danny De Looze Department of Gastroenterology University Hospital Gent, Belgi...

    Find out more

    Focus on antibiotic associated diarrhea (AAD)

    Find out more

    Dampening gastrointestinal inflammation through nutrition

    by Dr Genelle Healey

    Find out more

    Continue reading

    News
    Actu PRO : Malnutrition : agir sur le microbiote pour améliorer la croissance, un prototype à l’essai
    08.07.2021

    Malnutrition: acting on the microbiota in order to improve growth, a trial prototype

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    07.02.2025

    Your functional dyspepsia diagnosis check list

    Read the article
    17.04.2025

    Sensitivity to the additive E466: the role of the microbiota

    Read the article
    Photo HCPs: Clinical context over quick fix: the fresh consensus on microbiome testing
    11.04.2025

    Clinical context over quick fix: the fresh consensus on microbiome testing

    Read the article
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article
    Actu PRO : Alcoolisme : expliquer les troubles sociaux grâce au microbiote
    27.01.2021

    Alcoholism: explaining social disorders thanks to the microbiota

    Read the article
    20.03.2025

    Entacapone and the gut: a hidden impact on parkinson’s care

    Read the article
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo